IPC
SUPN icon

Independent Portfolio Consultants’s Supernus Pharmaceuticals SUPN Stock Holding History

Independent Portfolio Consultants’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$42K Sell
970
-1,385
-59% -$49.3K 0.02% 535
2017
Q1 		$74K Sell
2,355
-880
-27% -$23.6K 0.03% 505
2016
Q4 		$82K Buy
3,235
+40
+1% +$894 0.03% 477
2016
Q3 		$79K Sell
3,195
-1,160
-27% -$26.3K 0.02% 475
2016
Q2 		$89K Sell
4,355
-555
-11% -$9.84K 0.03% 466
2016
Q1 		$75K Buy
+4,910
New +$64.1K 0.02% 513

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Independent Portfolio Consultants's SUPN Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Supernus Pharmaceuticals (SUPN) stake by 59% in Q2 2017, selling an estimated $49.3K and leaving 970 shares worth $42K. The position accounts for 0.02% of the portfolio, ranked #535.

Independent Portfolio Consultants first reported a position in SUPN in Q1 2016 and has held it in 6 quarters since. The position peaked at $89K in Q2 2016. 266 funds tracked by Wall St. Rank hold SUPN as of Q2 2017.

  • Independent Portfolio Consultants held 970 shares of Supernus Pharmaceuticals worth $42K as of Q2 2017.
  • Independent Portfolio Consultants sold 1,385 Supernus Pharmaceuticals shares in Q2 2017, an estimated $49.3K.
  • Supernus Pharmaceuticals made up 0.02% of Independent Portfolio Consultants's portfolio in Q2 2017, its #535 holding.
  • Independent Portfolio Consultants first reported a position in Supernus Pharmaceuticals in Q1 2016 and has held it in 6 quarters since.
  • Independent Portfolio Consultants's Supernus Pharmaceuticals position peaked at $89K in Q2 2016.
  • 266 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.